ORGNWednesday, 31 August 2005

2:30 PM-5:00 PM Washington DC Convention Center -- Ballroom C, Oral
Technical Achievements in Organic Chemistry Awards
Organizer:Robert A. Volkmann
Presiding:Donna Huryn
2:30 PMProcess development of AAE421: A somatostatin sst1 receptor antagonist
Yansong J Lu, Bin Hu, Mahavir Prashad, Oljan Repič, Thomas J. Blacklock
3:00 PMProcess development of the hNK-1 receptor antagonist Aprepitant: From preclinical supplies to product launch
Joseph F Payack, Karel M. J. Brands, Dongwei Cai, Ian F. Cottrell, Paul N. Devine, Karl Hansen, David L. Hughes, Mark A. Huffman, James McNamara, Todd D. Nelson, Philip J. Pye, Jonathan D. Rosen
3:30 PMDevelopment of a manufacturing process for Δ 9(11)-canrenone
Mark J. Pozzo
4:00 PMApplication of crystallization technologies to process development and manufacture of active pharmaceutical ingredients
Peter R. Rose
4:30 PMI: Synthesis and structure activity relationship of novel SSRI/5HT1A antagonists. II: Design and synthesis of 1,3-dihydrobenzimidazole-2-ones, 1,3-dihydobenzimidazole-2-thiones and 1,4-dihydroquinoxalines as dopamine D2 agonists
Uresh Shah, Deborah A. Evrard, Gary Stack, Richard Mewshaw, Dahui Zhou, James Nelson

Previous Session -- Technical Achievements in Organic Chemistry Awards

Symposium Grid -- Division of Organic Chemistry -- Session Listing

The 230th ACS National Meeting, in Washington, DC, Aug 28-Sept 1, 2005